Trifecta and Carpentier Edwards aortic bioprostheses: Comparison of six years follow-up outcomes.
Aortic valve replacement
aortic bioprosthesis
degenerative disease
mean transvalvular gradient
structural valve disease
Journal
Asian cardiovascular & thoracic annals
ISSN: 1816-5370
Titre abrégé: Asian Cardiovasc Thorac Ann
Pays: England
ID NLM: 9503417
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
medline:
5
7
2023
pubmed:
31
3
2023
entrez:
30
3
2023
Statut:
ppublish
Résumé
To compare mid-term clinical outcomes and hemodynamic performance of the stented pericardial Trifecta bioprosthesis for surgical aortic valve replacement (AVR) with a technically comparable commonly used surgical bioprosthesis. Data from consecutive patients implanted with the TF or the Carpentier Edwards Magna Ease valve were retrospectively analyzed. Primary analysis was performed on a propensity score-matched cohort. Primary endpoints included the composite of death or reoperation and structural valve deterioration. The comparison also included echocardiographic assessments at one-week post-AVR and at the last documented follow-up. Two propensity score-matched groups of 170 patients each were identified from the overall population ( The Trifecta valve is a valuable alternative to the Carpentier Edwards valve in terms of safety, hemodynamic performance, and mid-term durability. Smaller-sized valves provide additional clinical benefits, given their persistent hemodynamic advantages through mid-term follow-up.
Sections du résumé
BACKGROUND
BACKGROUND
To compare mid-term clinical outcomes and hemodynamic performance of the stented pericardial Trifecta bioprosthesis for surgical aortic valve replacement (AVR) with a technically comparable commonly used surgical bioprosthesis.
METHODS
METHODS
Data from consecutive patients implanted with the TF or the Carpentier Edwards Magna Ease valve were retrospectively analyzed. Primary analysis was performed on a propensity score-matched cohort. Primary endpoints included the composite of death or reoperation and structural valve deterioration. The comparison also included echocardiographic assessments at one-week post-AVR and at the last documented follow-up.
RESULTS
RESULTS
Two propensity score-matched groups of 170 patients each were identified from the overall population (
CONCLUSION
CONCLUSIONS
The Trifecta valve is a valuable alternative to the Carpentier Edwards valve in terms of safety, hemodynamic performance, and mid-term durability. Smaller-sized valves provide additional clinical benefits, given their persistent hemodynamic advantages through mid-term follow-up.
Identifiants
pubmed: 36991560
doi: 10.1177/02184923231166339
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM